For Research Use Only. Tirzepatide (GLP-2 TZ) is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
Why Tirzepatide Sourcing Requires Specific Attention
Tirzepatide is a lipidated modified peptide with dual receptor agonist activity. The sequence is designed to engage both the GLP-1 and the GIP receptor, which requires specific amino acid compositions that support dual binding. The lipidation chemistry extends the plasma half life through albumin binding, similar to the strategy used for GLP-1 SM.
The analytical characterization of tirzepatide has to confirm both the correct peptide sequence and the correct lipidation. The mass spectrometric analysis must account for the lipid chain, and the purity specification must resolve the correctly modified product from any incompletely modified byproducts. These analytical requirements are the same in kind as for GLP-1 SM but distinct in specific implementation because the base peptide and the lipidation site differ between the two compounds. The technical context for these analytics is covered in the peptide bioanalysis article in the umbrella cluster.
Midwest Peptide supplies GLP-2 TZ 30mg as research grade material with third party certificates of analysis that cover the full modified peptide characterization.
Research Grade Sourcing Criteria for GLP-2 TZ
Third party certificate of analysis confirming the lipidation. The certificate should document the full modified peptide by mass spectrometry, with the observed mass matching the theoretical mass of the lipidated compound.
Purity specification from HPLC. Research grade GLP-2 TZ from Midwest Peptide is supplied at a minimum of ninety five percent HPLC purity. The lot specific purity value is on the certificate of analysis.
Sequence confirmation. The peptide sequence should be confirmed by tandem mass spectrometry or equivalent sequencing, with particular attention to the residues that confer dual receptor agonist activity.
Lot traceability. Every vial carries a lot number that traces back to the production batch, enabling reproducibility across studies.
Research appropriate formulation. GLP-2 TZ is supplied as a lyophilized powder in research appropriate vial formats. The standard Midwest Peptide catalog unit is thirty milligrams per vial.
Research use only compliance. The product is labeled strictly for research use only. The GLP-2 TZ research cluster covers the preclinical research applications including beta-cell research, hepatic research, body composition research, and GIP receptor biology.
Shipping. Domestic shipping from Mission, Kansas through ShipStation and UPS with tracking on every order.
Payment flexibility. Zelle (five percent discount), CashApp, Venmo, Azeban Pay credit and debit cards, and Coinbase Commerce cryptocurrency.
Research support. Direct support through 636-734-2390 and the contact page on the Midwest Peptide website.
Red Flags When Evaluating Tirzepatide Suppliers
No lipidation confirmation on the certificate. The lipidation has to be explicitly confirmed by mass spectrometry. A certificate showing only the unmodified peptide mass is inadequate.
Purity below ninety five percent or no stated purity. Research grade tirzepatide requires a defined purity specification with lot specific values.
Internal certificate only. Third party certificates provide the independent verification that research buyers should expect.
Health claims or implied human use. Any supplier describing tirzepatide as therapeutic is operating outside the research use only framework.
Unclear distinction from GLP-1 SM. The two compounds are related but chemically distinct. A supplier that conflates them or does not clearly identify which compound is being supplied is not positioned for rigorous research supply.
Opaque supplier. Legitimate suppliers have known physical locations and real customer support channels.
What GLP-2 TZ Is Studied For in Research
The full research landscape is covered in the GLP-2 TZ research cluster. The short summary is that tirzepatide is studied in rodent and larger animal research models for effects on beta-cell function and mass, body composition and adipose biology, hepatic steatosis and inflammation, glucose regulation through the combined incretin mechanism, and comparative pharmacology with single GLP-1 receptor agonists and with triple receptor agonists.
The single versus dual agonist comparison provides the framework for understanding when tirzepatide is the appropriate research tool versus the alternatives. The dual incretin mechanism article covers the combined receptor pharmacology that defines the compound.
Comparison with GLP-1 SM and with GLP-3 RT is supported by the parallel catalog offerings through Midwest Peptide. The GLP-1 SM 20mg product provides the single GLP-1 receptor agonist for comparison. The GLP-3 RT product provides the triple receptor agonist option.
Frequently Asked Sourcing Questions
What is the catalog size for GLP-2 TZ? The standard unit is GLP-2 TZ 30mg per vial, lyophilized powder.
What is the purity specification? Minimum ninety five percent HPLC purity with full lipidation confirmation.
What is the shipping timeline? Two to four business days to continental United States locations via ShipStation and UPS with tracking.
What payment methods are accepted? Zelle (five percent discount), CashApp, Venmo, Azeban Pay, and Coinbase Commerce.
Can I get GLP-2 TZ alongside other incretin agonists for comparative research? Yes. The catalog includes GLP-1 SM 20mg, GLP-3 RT, and Cagrilintide 5mg for related research applications.